Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11476043 | 1.00 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| SCHEMBL25522980 | 1.00 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| SCHEMBL26757190 | 1.00 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| Fluoride Ion SCHEMBL7549471 | 0.97 | — | — | |
| SCHEMBL7554136 | 0.97 | TSHR (0.32) | — | |
| Water SCHEMBL1116006 | 0.97 | — | — | |
| Iodide SCHEMBL2581384 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL3022712 | 0.97 | — | — | |
| Bromide SCHEMBL7780865 | 0.97 | — | — | |
| SCHEMBL7554132 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 823 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382189-A1 | ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS | BASF MOBILE EMISSIONS CATALYSTS LLC (US) | 2025-12-18 | — | — | US | claimed |
| US-12428305-B2 | Zeolite structure synthesized using mixtures of organic structure directing agents | BASF MOBILE EMISSIONS CATALYSTS LLC (US) | 2025-09-30 | — | — | US | claimed |
| US-20250205690-A1 | A CHA TYPE ZEOLITE AND THE METHOD OF SYNTHESISING SAID ZEOLITE | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2025-06-26 | — | — | US | claimed |
| US-20250121364-A1 | METHODS OF MAKING ZEOLITE BETA MATERIALS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-04-17 | — | — | US | claimed |
| WO-2025080821-A1 | METHODS OF MODIFYING ZEOLITE BETA MATERIALS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-04-17 | — | — | WO | claimed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| EP-4526253-A1 | A CHA TYPE ZEOLITE AND THE METHOD OF SYNTHESISING SAID ZEOLITE | Johnson Matthey Public Limited Company (GB) | 2025-03-26 | — | — | EP | claimed |
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | claimed |
| CN-119059497-A | Process for the production of onium salts of bis (fluorosulfonyl) imide | 法国特种经营公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118984809-A | CHA type zeolite and method for synthesizing the same | 庄信万丰股份有限公司 | 2024-11-19 | — | — | CN | claimed |
| WO-2005063623-A2 | CHABAZITE-CONTAINING MOLECULAR SIEVE, ITS SYNTHESIS AND ITS USE IN THE CONVERSION OF OXYGENATES TO OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-07-14 | — | — | WO | claimed |
| US-20040266870-A1 | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | DOMPÉ FARMACEUTICI S.P.A. (IT) | 2004-12-30 | — | — | US | claimed |
| EP-1430020-A1 | QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dompé S.P.A. (IT) | 2004-06-23 | — | — | EP | claimed |
| WO-2003029187-A1 | QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE S.P.A. (IT) | 2003-04-10 | — | — | WO | claimed |
| EP-0684248-B1 | Process for the preparation of tertiary diarylalkylphosphines | CELANESE CHEM EUROPE GMBH (DE) | 2001-08-29 | — | — | EP | claimed |
| US-6280900-B1 | RADIATION SENSITIVE COMPOSITION WITH ALKALINE DEVELOPER SOLUBLE IN POLYMER COATED ON SUBSTRATE | JSR CORPORATION (JP) | 2001-08-28 | — | — | US | claimed |
| US-5527967-A | Process for preparing tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | claimed |
| EP-0684248-A1 | Process for the preparation of tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-29 | — | — | EP | claimed |
| US-4610854-A | CYCLOHEXYL OR CYCLOPENTYL TRIMETHYLAMMONIUM IONS | CHEVRON RESEARCH COMPANY (US) | 1986-09-09 | — | — | US | claimed |
| US-4355153-A | QUATERNARY AMMONIUM LACTAMATE CATALYST | SOCIETA' ITALIANA RESINE S.I.R. S.P.A. (IT) | 1982-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | ALDH1A1 3764/4885HSD17B10 2452/4885 |
| US-20040266870-A1 | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | C3AR1, IL5, AP1G1 | ALDH1A1 1940/4885HSD17B10 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.